Physician-prescribed Semaglutide and Tirzepatide programs — paired with lab work, dose titration, and real clinical oversight. Not a subscription box. A supervised medical program built around your body.
GLP-1 (glucagon-like peptide-1) is a hormone your gut already produces after you eat. It tells your brain you are full, slows how quickly food leaves your stomach, and helps your pancreas regulate blood sugar.
GLP-1 receptor agonists — the class that includes Semaglutide and Tirzepatide — are lab-made versions of that same hormone, engineered to last about a week instead of a few minutes. They do not speed up your metabolism or burn fat directly. They restore the fullness signal that makes eating less feel natural rather than forced.
Not a stimulant. Not a crash diet. A hormone your body already knows.
Weight loss on a GLP-1 is not about willpower. It is about four measurable physiological shifts that happen once the medication reaches a therapeutic dose.
GLP-1 receptors in the hypothalamus register fullness earlier, so satisfaction arrives after a smaller portion.
Food stays in your stomach longer, extending fullness for hours instead of the usual 60–90 minutes.
Insulin release is sharpened and glucagon suppressed, flattening the spikes and crashes that drive cravings.
Most patients report the constant background chatter about food quiets down within the first few weeks.
Both are once-weekly injections and both work. The difference is how many receptors they activate — and that difference shows up in the average results.
The most studied GLP-1 for weight management, with a long real-world safety record. A strong first choice for most patients, and typically the more affordable entry point.
The added GIP action improves how your body stores and uses fat, which in head-to-head trials produced greater average weight loss and often better tolerability at comparable doses.
Figures reflect published clinical-trial averages at maintenance dose over 68–72 weeks. Individual results vary; your provider will recommend the medication that fits your history, goals, and tolerance.
Every program starts with a consultation and lab work. Here is the general framework your provider will use.
This list is educational, not a diagnosis. Only a licensed provider reviewing your full history and labs can determine whether GLP-1 therapy is safe for you.
Weight loss on a GLP-1 is gradual and dose-dependent. Knowing the arc in advance is the single best predictor of sticking with it.
You begin at the lowest dose to let your body adjust. Appetite usually drops within 1–2 weeks. Mild nausea or constipation is common and typically fades. Weight change is small — that is expected.
Your dose steps up every 4 weeks toward a therapeutic level. This is where consistent, visible weight loss begins — commonly 1–2 lbs per week.
You reach and hold your effective dose. Most patients are 10–15% down by month six. Protein intake and resistance training now matter most for protecting lean muscle.
You and your provider decide whether to continue, taper, or hold. A maintenance plan protects your results — this is the step most programs skip.
Medication alone is the easy part. What determines whether the weight stays off is everything wrapped around it.
A licensed clinician reviews your history, sets your protocol, and adjusts it as you progress — virtually or in person.
Metabolic panel, A1c, thyroid, and liver function checked before you start and monitored throughout.
Your prescription, needles, and sharps container shipped in temperature-controlled packaging.
Side effect questions answered by your care team in days, not weeks. No call centers.
Protein targets, hydration, and meal structure designed for a reduced appetite — so you lose fat, not muscle.
Weight, measurements, and where available body composition, so you can see what is actually changing.
Transparent monthly pricing. Medication, labs, and provider oversight are included — no hidden compounding or consultation fees.
Weekly injectable GLP-1 for steady, sustainable weight loss.
Dual-action GLP-1 + GIP therapy for enhanced results.
GLP-1 therapy plus IV nutrient support and body composition tracking.
Pricing reflects medication and program cost. Your consultation determines eligibility and your exact plan. Programs are month-to-month with no long-term contract.
Tell us your health history and goals. A provider confirms whether GLP-1 therapy makes sense for you.
Quick blood work establishes your baseline and rules out contraindications before anything is prescribed.
Your personalized starting dose ships to your door with everything you need to self-inject confidently.
Scheduled check-ins, dose titration, and follow-up labs keep your plan safe and effective.
Most people tolerate GLP-1s well, but side effects are real and worth understanding before you start.
Most often appear in the first days after a dose increase and settle within a few weeks.
Side effects are largely a dosing problem. Slower titration solves most of them.
Severe or persistent abdominal pain radiating to the back, ongoing vomiting, signs of gallbladder problems, a rapid heartbeat, or any new lump or swelling in the neck. These are uncommon, but they are not side effects to wait out.
Every plan is prescribed and monitored by a licensed clinician who knows your history — not an algorithm issuing a standard script.
Required labs and scheduled check-ins mean your dose is always matched to how your body is actually responding.
Medication delivered to your door, consultations virtual or in person, and a care team that answers you directly.
Most adults with a BMI of 30 or higher — or 27 or higher with a weight-related condition such as prediabetes, high blood pressure, sleep apnea, or high cholesterol — are candidates. Your free consultation and baseline lab work confirm eligibility and determine the right starting dose. Patients with a personal or family history of medullary thyroid carcinoma or MEN2, a history of pancreatitis, or who are pregnant or breastfeeding are not candidates.
Semaglutide activates the GLP-1 receptor. Tirzepatide activates both GLP-1 and GIP receptors, and in clinical trials that dual action produced greater average weight loss — roughly 15–22% of body weight versus 10–15%. Tirzepatide is generally the stronger option, but Semaglutide has a longer real-world track record and a lower monthly cost. Your provider recommends based on your BMI, health history, and how you tolerate the starting dose.
Published trials show average reductions of 10–15% of body weight on Semaglutide and 15–22% on Tirzepatide over roughly 68–72 weeks at maintenance dose. For a 220 lb starting weight, that is about 22–33 lbs on Semaglutide or 33–48 lbs on Tirzepatide. Results vary considerably based on starting weight, dose reached, nutrition, activity, and consistency. Patients who pair the medication with adequate protein and resistance training keep more lean muscle and tend to hold their results longer.
The most common are nausea, constipation, diarrhea, and fatigue, usually in the first days after a dose increase, and usually fading within a few weeks. They are largely dose-related, which is why we titrate slowly and will hold or reduce a dose rather than push you through symptoms. Serious side effects such as pancreatitis or gallbladder disease are uncommon but real, and we screen for risk factors in your baseline labs and history.
